Market Overview:
The global injectable for cosmetic surgery market is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. The market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into botulinum toxin, soft tissue fillers, dermal fillers, lasers, and others. Botulinum toxin held a dominant share in 2017 and is expected to maintain its dominance during the forecast period as well. This can be attributed to its increasing use in aesthetic procedures such as wrinkle treatment and crow’s feet treatment. Soft tissue fillers are also anticipated to witness high growth during the forecast period owing to their increasing use in lip augmentation procedures. On the basis of application, hospitals accounted for a major share of the global injectable for cosmetic surgery market in 2017 and this trend is projected to continue duringthe forecast period as well owingto rising numberof surgical procedures being performedin these settings globally .
Product Definition:
Injectable for Cosmetic Surgery is a substance which is injected into the skin to improve the appearance of wrinkles, scars or other blemishes. This can be done with a variety of substances, including Botox, collagen and hyaluronic acid. Injectables can help to smooth out the skin's surface and create a more youthful appearance.
Botulinum Toxin:
Botulinum toxin is a neurotoxin and it's produced by an anaerobic bacterium, Clostridium botulinum. It has the ability to relax muscles which enables it's use in cosmetic surgery for facial lines, neck and décolletage among others. The major factor driving the growth of this segment is increasing demand for anti aging products coupled with growing geriatric population base across the globe.
Soft Tissue Fillers:
Soft tissue fillers are used to enhance the volume and/or improve the contours of face, neck, arms, and legs. It is also used in breast augmentation procedures as it helps in enhancing shape and size of breasts. Soft tissue filler injections have gained popularity due to minimally invasive nature coupled with rapid recovery rate as compared to traditional surgeries.
Application Insights:
Based on application, the global injectable for cosmetic surgery market is segmented into hospitals, dermatology clinics and beauty centers, other medical spas/outlets, and surgical centers. Hospitals held the largest share in 2017 owing to increasing number of procedures performed at a hospital compared to other locations. Hospital based surgeries are more cost-effective as compared to outpatient surgeries. In addition, hospitals offer better patient amenities such as recovery rooms with proper equipment and staff monitoring ensuring faster healing process resulting in shorter duration of postoperative care which eventually reduces overall cost associated with it.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in demand for cosmetic surgery and growing awareness about available treatments. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by companies and introduction of technologically advanced products. In addition, presence of key players is also likely to contribute towards growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing with rapid economic development coupled with rising disposable income especially in developing countries such as China & India will drive this regional market at a significant pace during the forecast period.
Europe was estimated as second largest regional segment followed by North America in 2017 due high product availability.
Growth Factors:
- Increasing demand for minimally invasive cosmetic surgery procedures: The popularity of minimally invasive cosmetic surgery procedures is increasing due to the numerous benefits they offer over traditional surgical procedures. Injectable treatments are among the most popular minimally invasive procedures, and this is expected to drive growth in the injectable for cosmetic surgery market in the coming years.
- Growing demand for non-surgical aesthetic treatments: A growing number of people are opting for non-surgical aesthetic treatments such as injectables in order to achieve a more youthful appearance without having to go through surgery. This is contributing to growth in the injectable for cosmetic surgery market.
- Advances in technology and product innovation: The injectable for cosmetic surgery market is benefiting from advances in technology and product innovation that are making these products more effective and safer than ever before. This is helping fuel growth in the market’s overall size.
Scope Of The Report
Report Attributes
Report Details
Report Title
Injectable for Cosmetic Surgery Market Research Report
By Type
Botulinum Toxin, Soft Tissue Fillers, Dermal Fillers, Lasers, Others,
By Application
Hospitals, Dermatology Clinics, Beauty Centers, Othes,
By Companies
Allergan, Mentor, Candela, Cutera, Lumenis, Palomar Medical, Iridex, Solta Medical, DermaMed Pharma, Medtronic, Johnson & Johnson, Syneron Medical, Cynosure
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Injectable for Cosmetic Surgery Market Report Segments:
The global Injectable for Cosmetic Surgery market is segmented on the basis of:
Types
Botulinum Toxin, Soft Tissue Fillers, Dermal Fillers, Lasers, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Dermatology Clinics, Beauty Centers, Othes,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Mentor
- Candela
- Cutera
- Lumenis
- Palomar Medical
- Iridex
- Solta Medical
- DermaMed Pharma
- Medtronic
- Johnson & Johnson
- Syneron Medical
- Cynosure
Highlights of The Injectable for Cosmetic Surgery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Botulinum Toxin
- Soft Tissue Fillers
- Dermal Fillers
- Lasers
- Others
- By Application:
- Hospitals
- Dermatology Clinics
- Beauty Centers
- Othes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Injectable for Cosmetic Surgery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Injectable fillers are a type of cosmetic surgery that use injections to add volume, shape, and contour to the face. They can be used for both facial and body filler procedures.
Some of the major players in the injectable for cosmetic surgery market are Allergan, Mentor, Candela, Cutera, Lumenis, Palomar Medical, Iridex, Solta Medical, DermaMed Pharma, Medtronic, Johnson & Johnson, Syneron Medical, Cynosure.
The injectable for cosmetic surgery market is expected to grow at a compound annual growth rate of 7.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Injectable for Cosmetic Surgery Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Injectable for Cosmetic Surgery Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Injectable for Cosmetic Surgery Market - Supply Chain
4.5. Global Injectable for Cosmetic Surgery Market Forecast
4.5.1. Injectable for Cosmetic Surgery Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Injectable for Cosmetic Surgery Market Size (000 Units) and Y-o-Y Growth
4.5.3. Injectable for Cosmetic Surgery Market Absolute $ Opportunity
5. Global Injectable for Cosmetic Surgery Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Injectable for Cosmetic Surgery Market Size and Volume Forecast by Type
5.3.1. Botulinum Toxin
5.3.2. Soft Tissue Fillers
5.3.3. Dermal Fillers
5.3.4. Lasers
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Injectable for Cosmetic Surgery Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Injectable for Cosmetic Surgery Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Dermatology Clinics
6.3.3. Beauty Centers
6.3.4. Othes
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Injectable for Cosmetic Surgery Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Injectable for Cosmetic Surgery Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Injectable for Cosmetic Surgery Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Injectable for Cosmetic Surgery Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Injectable for Cosmetic Surgery Demand Share Forecast, 2019-2026
9. North America Injectable for Cosmetic Surgery Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Injectable for Cosmetic Surgery Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Injectable for Cosmetic Surgery Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Dermatology Clinics
9.4.3. Beauty Centers
9.4.4. Othes
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Injectable for Cosmetic Surgery Market Size and Volume Forecast by Type
9.7.1. Botulinum Toxin
9.7.2. Soft Tissue Fillers
9.7.3. Dermal Fillers
9.7.4. Lasers
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Injectable for Cosmetic Surgery Demand Share Forecast, 2019-2026
10. Latin America Injectable for Cosmetic Surgery Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Injectable for Cosmetic Surgery Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Injectable for Cosmetic Surgery Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Dermatology Clinics
10.4.3. Beauty Centers
10.4.4. Othes
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Injectable for Cosmetic Surgery Market Size and Volume Forecast by Type
10.7.1. Botulinum Toxin
10.7.2. Soft Tissue Fillers
10.7.3. Dermal Fillers
10.7.4. Lasers
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Injectable for Cosmetic Surgery Demand Share Forecast, 2019-2026
11. Europe Injectable for Cosmetic Surgery Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Injectable for Cosmetic Surgery Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Injectable for Cosmetic Surgery Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Dermatology Clinics
11.4.3. Beauty Centers
11.4.4. Othes
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Injectable for Cosmetic Surgery Market Size and Volume Forecast by Type
11.7.1. Botulinum Toxin
11.7.2. Soft Tissue Fillers
11.7.3. Dermal Fillers
11.7.4. Lasers
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Injectable for Cosmetic Surgery Demand Share, 2019-2026
12. Asia Pacific Injectable for Cosmetic Surgery Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Injectable for Cosmetic Surgery Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Injectable for Cosmetic Surgery Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Dermatology Clinics
12.4.3. Beauty Centers
12.4.4. Othes
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Injectable for Cosmetic Surgery Market Size and Volume Forecast by Type
12.7.1. Botulinum Toxin
12.7.2. Soft Tissue Fillers
12.7.3. Dermal Fillers
12.7.4. Lasers
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Injectable for Cosmetic Surgery Demand Share, 2019-2026
13. Middle East & Africa Injectable for Cosmetic Surgery Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Injectable for Cosmetic Surgery Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Injectable for Cosmetic Surgery Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Dermatology Clinics
13.4.3. Beauty Centers
13.4.4. Othes
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Injectable for Cosmetic Surgery Market Size and Volume Forecast by Type
13.7.1. Botulinum Toxin
13.7.2. Soft Tissue Fillers
13.7.3. Dermal Fillers
13.7.4. Lasers
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Injectable for Cosmetic Surgery Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Injectable for Cosmetic Surgery Market: Market Share Analysis
14.2. Injectable for Cosmetic Surgery Distributors and Customers
14.3. Injectable for Cosmetic Surgery Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mentor
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Candela
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cutera
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lumenis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Palomar Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Iridex
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Solta Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. DermaMed Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Medtronic
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Johnson & Johnson
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Syneron Medical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Cynosure
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
